Michael Kazim1, Katherine G Gold. 1. Department of Ophthalmology, Division of Ophthalmic Plastic and Reconstructive Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA. mk48@columbia.edu
Abstract
PURPOSE OF REVIEW: We review the literature pertinent to surgical correction of upper eyelid retraction resulting from thyroid eye disease (TED). RECENT FINDINGS: Although novel nonsurgical treatment of TED-upper eyelid retraction has been described, with botulinum A toxin and hyaluronic acid; graded full-thickness blepharotomy remains the mainstay of treatment for the condition. SUMMARY: Graded full-thickness anterior blepharotomy provides predictable, reproducible results and is a simple surgical procedure to master. For patients who cannot undergo surgical intervention, botulinum toxin offers a novel nonsurgical answer to lid retraction, but may be complicated by overcorrection and introduces an additional variable that needs to be considered when following the patient.
PURPOSE OF REVIEW: We review the literature pertinent to surgical correction of upper eyelid retraction resulting from thyroid eye disease (TED). RECENT FINDINGS: Although novel nonsurgical treatment of TED-upper eyelid retraction has been described, with botulinum A toxin and hyaluronic acid; graded full-thickness blepharotomy remains the mainstay of treatment for the condition. SUMMARY: Graded full-thickness anterior blepharotomy provides predictable, reproducible results and is a simple surgical procedure to master. For patients who cannot undergo surgical intervention, botulinum toxin offers a novel nonsurgical answer to lid retraction, but may be complicated by overcorrection and introduces an additional variable that needs to be considered when following the patient.
Authors: Que Anh Vu; Thu Hien Nguyen; Van Anh Bui; Khanh Van Pham; Joohyun Kim; Sehyun Baek Journal: Ophthalmic Plast Reconstr Surg Date: 2021-08-25 Impact factor: 2.011